Literature DB >> 11998922

Mydriasis due to self-administered inhaled ipratropium bromide.

David W Bond, Harish Vyas, Helen E Venning.   

Abstract

Mydriasis due to ipratropium bromide has previously been described in children and adults. Children as young as 4 years of age may attempt to self-administer their inhalers. This possibility should be considered if an asthmatic child presents with abnormal neurological signs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11998922     DOI: 10.1007/s00431-001-0885-5

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  6 in total

1.  Unilateral fixed dilated pupil in an infant after inhalation of nebulized ipratropium bromide.

Authors:  J Woelfle; S Zielen; M J Lentze
Journal:  J Pediatr       Date:  2000-03       Impact factor: 4.406

2.  Acute angle closure glaucoma associated with nebulised ipratropium bromide and salbutamol.

Authors:  P Shah; L Dhurjon; T Metcalfe; J M Gibson
Journal:  BMJ       Date:  1992-01-04

3.  Ipratropium and the eye.

Authors:  P G Tuohy
Journal:  N Z Med J       Date:  1989-07-26

4.  Unilateral pharmacologic mydriasis in a patient with respiratory compromise.

Authors:  J B Goldstein; V Biousse; N J Newman
Journal:  Arch Ophthalmol       Date:  1997-06

5.  Ipratropium bromide induced unilateral mydriasis.

Authors:  C A Ryan
Journal:  Ir Med J       Date:  1997-03

6.  Effect of nebulized ipratropium bromide on intraocular pressures in children.

Authors:  W T Watson; E P Shuckett; A B Becker; F E Simons
Journal:  Chest       Date:  1994-05       Impact factor: 9.410

  6 in total
  1 in total

1.  Anisocoria in a 10-month old girl in the immediate preoperative setting: can you proceed with surgery?

Authors:  Zoel A Quinonez; Niroop R Ravula
Journal:  J Biomed Res       Date:  2011-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.